DDX21 and breast carcinoma: Additionally, DDX21 interacts with EZH2 and SUZ12 at the SNAIL promoter to enhance H3K27me3, epigenetically repressing SNAIL transcription and thereby inhibiting epithelial–mesenchymal transition (EMT) and suppressing breast cancer cell invasion and metastasis [35].